Financials
Financial year 2025
PHARMACIE DEMEULDRE - DEGIVE from Esneux, company number BE0479329260, closed financial year 2025 with a result of € 21,607 after tax. For that financial year PHARMACIE DEMEULDRE - DEGIVE recorded a gross margin of € 172,114 and equity of € 175,824. Compared with financial year 2024, the result moved from € 3,118 to € 21,607. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 175,824
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 21,607
▲ € 18,489 vs 2024
Profit after tax over the fiscal year.
€ 67,552
Cash and bank balances on the last day of the fiscal year.
€ 21,500 paid out
100 % of the profit went to the shareholders, mostly to ANNE-SOPHIE KAISER GESTION (100 % of the shares). That is where the money ends up.
People and assets in 2025
1.9
Average over the fiscal year, from the social balance sheet.
€ 121,949
▼ 10% vs 2024
€ 64,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,963
▲ 240% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 246,087
▼ 8% vs 2024
€ 18,392 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.
€ 80,308
▲ 8% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,272
▼ 27% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 134,893 | € 152,522 | € 167,896 | € 172,114 | ▲ 3% |
| Profit after taxes | € 14,219 | € 177 | € 3,118 | € 21,607 | ▲ € 18,489 |
| Equity | € 175,422 | € 175,598 | € 175,716 | € 175,824 | |
| Total debts | € 455,241 | € 426,959 | € 431,818 | € 429,017 | ▼ 1% |
| Cash | € 53,535 | € 42,484 | € 67,491 | € 67,552 | |
| Land & buildings | € 333,939 | € 324,727 | € 315,515 | € 308,662 | ▼ 2% |
| Retained profit | € 95,297 | € 95,473 | € 95,591 | € 95,699 | |
| Dividend | € 13,500 | € 0 | € 3,000 | € 21,500 | ▲ € 18,500 |
| Bank debt | € 315,401 | € 291,668 | € 267,457 | € 246,087 | ▼ 8% |
| Balance sheet total | € 630,662 | € 602,557 | € 607,535 | € 604,841 | |
| Employees (FTE) | 1.5 | 1.5 | 1.9 | 1.9 |
Key figures of PHARMACIE DEMEULDRE - DEGIVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DEMEULDRE - DEGIVE?
What happened at PHARMACIE DEMEULDRE - DEGIVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 21,607 (▲ € 18,489 vs 2024). filed late Source: NBB ↗
- Anne-Sophie Kaiser Gestion became a director. NBB
- New establishment in Esneux. KBO
- Start of the company according to the CBE. KBO
In short
From € 14,219 profit in 2022 to € 21,607 profit in 2025.
Paid € 3,509 in corporate taxes since 2022.
Best year ever: 2025, with € 21,607 profit.
On average € 90,600 of value added per employee in 2025.
A new publication or filing at PHARMACIE DEMEULDRE - DEGIVE? We notify you, reason included.
Follow PHARMACIE DEMEULDRE - DEGIVEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ANNE-SOPHIE KAISER GESTION comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DEMEULDRE - DEGIVEBehind PHARMACIE DEMEULDRE - DEGIVE is Anne-Sophie Kaiser Gestion. The shares are held by ANNE-SOPHIE KAISER GESTION (100%).
Directors
According to the 2025 annual accounts
Director · represented by Anne-Sophie Kaiser
Also active at: PHARMAKAISER GRIVEGNEE
since 2021
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue des Combattants 16
4130 Esneux
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.329.260
- VAT number
- BE 0479.329.260
- Registered office
- Rue des Combattants 16, 4130 Esneux
- Names & denominations
- PHARMACIE DEMEULDRE - DEGIVE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 January 2003
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers